BG104726A - Нови производни на дихидроксихексанкарбонова киселина - Google Patents

Нови производни на дихидроксихексанкарбонова киселина

Info

Publication number
BG104726A
BG104726A BG104726A BG10472600A BG104726A BG 104726 A BG104726 A BG 104726A BG 104726 A BG104726 A BG 104726A BG 10472600 A BG10472600 A BG 10472600A BG 104726 A BG104726 A BG 104726A
Authority
BG
Bulgaria
Prior art keywords
novel derivatives
dihydroxyhexanoic acid
dihydroxyhexanoic
acid
derivatives
Prior art date
Application number
BG104726A
Other languages
English (en)
Inventor
John KATH
Matthew Brown
Christopher POSS
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of BG104726A publication Critical patent/BG104726A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Съединенията се използват при лечение на възпаления и други имунни нарушения. Производните на дихидроксихексанкарбоновата киселина имат обща формулав която заместителите имат посочените в описанието значения.
BG104726A 1998-02-05 2000-08-29 Нови производни на дихидроксихексанкарбонова киселина BG104726A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7380198P 1998-02-05 1998-02-05
PCT/IB1999/000067 WO1999040061A2 (en) 1998-02-05 1999-01-18 Novel dihydroxyhexanoic acid derivatives

Publications (1)

Publication Number Publication Date
BG104726A true BG104726A (bg) 2001-04-30

Family

ID=22115885

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104726A BG104726A (bg) 1998-02-05 2000-08-29 Нови производни на дихидроксихексанкарбонова киселина

Country Status (37)

Country Link
EP (1) EP1051405B1 (bg)
JP (1) JP3693916B2 (bg)
KR (1) KR100385529B1 (bg)
CN (1) CN1177834C (bg)
AP (1) AP992A (bg)
AR (1) AR016175A1 (bg)
AT (1) ATE337307T1 (bg)
AU (1) AU752407B2 (bg)
BG (1) BG104726A (bg)
BR (1) BR9907655A (bg)
CA (1) CA2320388C (bg)
DE (1) DE69932920T2 (bg)
DZ (1) DZ2717A1 (bg)
EA (1) EA003137B1 (bg)
ES (1) ES2268847T3 (bg)
GT (1) GT199900011A (bg)
HK (1) HK1034969A1 (bg)
HR (1) HRP20000529B1 (bg)
HU (1) HUP0100832A3 (bg)
IL (1) IL137330A0 (bg)
IS (1) IS5562A (bg)
MA (1) MA26603A1 (bg)
MY (1) MY133125A (bg)
NO (1) NO20003965D0 (bg)
NZ (1) NZ505724A (bg)
OA (1) OA11448A (bg)
PA (1) PA8467301A1 (bg)
PE (1) PE20000243A1 (bg)
PL (1) PL342817A1 (bg)
SK (1) SK11262000A3 (bg)
TN (1) TNSN99013A1 (bg)
TR (1) TR200002248T2 (bg)
TW (1) TW470744B (bg)
UA (1) UA57824C2 (bg)
WO (1) WO1999040061A2 (bg)
YU (1) YU47100A (bg)
ZA (1) ZA99873B (bg)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1152752A1 (en) * 1999-01-29 2001-11-14 Millennium Pharmaceuticals, Inc. Methods for preventing graft rejection and ischemia-reperfusion injury
EP1204643B1 (en) * 1999-08-20 2008-06-04 Dow AgroSciences LLC Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
EP1498417A1 (en) * 2000-02-04 2005-01-19 Pfizer Products Inc. Heterocyclic amide derivatives
CA2399214A1 (en) 2000-02-04 2001-08-09 Matthew Frank Brown Novel heterocyclic amide derivatives
US6740636B2 (en) 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
US6746856B2 (en) 2000-08-09 2004-06-08 Pfizer Inc. Microbial conversion of bicyclic heteroaromatic compounds
EA006777B1 (ru) 2001-06-22 2006-04-28 Пфайзер Продактс Инк. Фармацевтические композиции адсорбатов аморфного лекарственного средства
ATE444060T1 (de) 2001-06-22 2009-10-15 Pfizer Prod Inc Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
DE10152351B4 (de) * 2001-10-18 2005-09-22 Schering Ag Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat
ES2305434T3 (es) 2002-02-01 2008-11-01 Pfizer Products Inc. Composiciones framaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
CA2484342A1 (en) * 2002-05-14 2003-11-20 Pfizer Products Inc. Methods for manufacture of dihydro-furan-2-one derivatives
BR0309930A (pt) * 2002-05-14 2005-02-09 Pfizer Prod Inc Derivados do ácido dihidroxihexanóico, seus intermediários e métodos de produção
EP1539715A1 (en) * 2002-08-12 2005-06-15 Pfizer Products Inc. Crystal forms of quinoxaline-2-carboxylic acid 4-carbamoyl- 1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl -amide
WO2004014342A1 (en) 2002-08-12 2004-02-19 Pfizer Products Inc. Pharmaceutical compositions of semi-ordered drugs and polymers
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
US20040087571A1 (en) * 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
MXPA06001417A (es) 2003-08-04 2006-05-15 Pfizer Prod Inc Composiciones farmaceuticas de adsorbatos de farmacos amorfos y materiales que forman microfases lipofilas.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923864A (en) * 1987-12-15 1990-05-08 Pfizer Inc. Certain heterocyclic-hexanamides useful for treating hypertension
ATE220661T1 (de) * 1994-10-19 2002-08-15 Novartis Erfind Verwalt Gmbh Antivirale ether von aspartat-protease-substrat- isosteren
DE19708106A1 (de) * 1997-02-28 1998-09-03 Bosch Gmbh Robert Einrichtung und Verfahren zur Information über Verkehrsstörungen

Also Published As

Publication number Publication date
CA2320388A1 (en) 1999-08-12
GT199900011A (es) 2000-07-20
SK11262000A3 (sk) 2001-01-18
JP2002502839A (ja) 2002-01-29
KR20010040684A (ko) 2001-05-15
KR100385529B1 (ko) 2003-05-27
WO1999040061A3 (en) 1999-10-21
CN1177834C (zh) 2004-12-01
IS5562A (is) 2000-07-14
DE69932920D1 (de) 2006-10-05
HRP20000529B1 (en) 2004-12-31
ES2268847T3 (es) 2007-03-16
AU1778999A (en) 1999-08-23
EA003137B1 (ru) 2003-02-27
ZA99873B (en) 2000-08-04
TNSN99013A1 (fr) 2005-11-10
DZ2717A1 (fr) 2003-09-01
HUP0100832A2 (hu) 2002-02-28
PA8467301A1 (es) 2000-05-24
PE20000243A1 (es) 2000-04-07
EA200000741A1 (ru) 2001-02-26
EP1051405B1 (en) 2006-08-23
UA57824C2 (uk) 2003-07-15
NO20003965L (bg) 2000-10-03
AP9901457A0 (en) 1999-03-31
MY133125A (en) 2007-10-31
AP992A (en) 2001-08-06
JP3693916B2 (ja) 2005-09-14
NZ505724A (en) 2003-02-28
CA2320388C (en) 2005-05-03
AR016175A1 (es) 2001-06-20
TR200002248T2 (tr) 2000-12-21
ATE337307T1 (de) 2006-09-15
DE69932920T2 (de) 2007-02-08
TW470744B (en) 2002-01-01
IL137330A0 (en) 2001-07-24
BR9907655A (pt) 2000-10-24
HUP0100832A3 (en) 2002-03-28
MA26603A1 (fr) 2004-12-20
CN1290255A (zh) 2001-04-04
HK1034969A1 (en) 2001-11-09
WO1999040061A2 (en) 1999-08-12
AU752407B2 (en) 2002-09-19
OA11448A (en) 2003-11-18
YU47100A (sh) 2002-11-15
EP1051405A2 (en) 2000-11-15
HRP20000529A2 (en) 2001-08-31
NO20003965D0 (no) 2000-08-04
PL342817A1 (en) 2001-07-02

Similar Documents

Publication Publication Date Title
BG104726A (bg) Нови производни на дихидроксихексанкарбонова киселина
MY121294A (en) Novel hexanoic acid derivatives.
BG103413A (bg) Производни на сулфиновата киселина, тяхното получаване и използване
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
BG104056A (bg) Триазолови съединения и използването им като допамин-d3-лиганди
HUP0004592A2 (hu) VCAM-1 expresszió gátlására alkalmas vegyületek és eljárások
MY115662A (en) Novel compounds with analgesic effect
BG104597A (bg) Инхибиране на raf киназа при използване на заместени хетероциклени карбамиди
BG101110A (bg) Заместени пиримидинови съединения и тяхното използване
MX9702658A (es) Derivados novedosos de acido carboxilico, su preparacion y uso.
BG103251A (bg) Оксадиазоли, методи за получаването им и приложението им като лекарствени средства
BG103310A (bg) Бензонафтиридини като бронхиални лечебни средства
BG105270A (bg) Тетрахидропиридоетери
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
MY115211A (en) Novel amino acid derivatives, their preparation and use
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
MY109722A (en) Azaoxindole derivatives.
ES8705448A1 (es) Procedimiento para la obtencion de derivados de piridina
IL112020A0 (en) Arylacetic acid derivatives, their preparation and their use as fungicides
BG101109A (bg) Пиридилтио-съединения,метод за получаването им иприложението им за борба с бактерии от рода хеликобактер
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
BG102814A (bg) Нови производни на карбоксилни киселини, тяхното получаване и използване
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.